Go to deals
Healthcare | Private Equity

Acutronic Group have been acquired by Vyaire Medical Inc.

Acutronic Group, a group of non-affiliated companies active in neonatal ventilation, has been acquired by Apax-backed Vyaire Medical Inc., the leading pure play medical device company in the respiratory space. Financial details have not been disclosed.

Acutronic Group, consisting of Acutronic Medical Systems AG (Switzerland) and MIM Medizinische Instrumente & Monitoring GmbH, (Germany), is a global innovation leader in the area of neonatal ventilation. The group's portfolio includes the fabian® ventilator platform, the monsoon® jet ventilator, the florian® monitor and complimentary airway management devices and software solutions. Acutronic Group has a high vertical integration in that all performance-critical device components and the disposable flow sensors are manufactured in-house. In recent years, innovative Acutronic Group has grown much faster than the market, taking significant market share away from large competitors in the global neonatal intensive care market. Founded in 1981, the company is located in Germany and Switzerland and its products are distributed in more than 90 countries.

Vyaire Medical is the leading pure play medical device company in the respiratory space. With approximately US$800 million in annual sales, the company is active in manufacturing and distributing both respiratory and anesthesia/surgical consumables as well as capital equipment for respiratory diagnostics and ventilation. Headquartered in Chicago, Illinois, Vyaire Medical was formed in October 2016 as a joint venture between Becton, Dickinson and Company and Apax Partners to serve healthcare customers with innovative device and service solutions across the respiratory and anesthesia business lines. Vyaire's brands have a 65-year track record of pioneering, innovating, and advancing respiratory diagnostics, ventilation, and anesthesia delivery and patient monitoring. From industry-pioneering brands that include Bird, Bear, and Jaeger to respected industry leaders AirLife®, Vital Signs®, Viasys, and many others – Vyaire Medical has nearly 27,000 distinct part numbers recognized, trusted and preferred by specialists in the respiratory therapy and anesthesiology healthcare markets worldwide.

Oaklins' team in Germany advised the private shareholders of Acutronic Medical Systems AG and MIM Medizinische Instrumente & Monitoring GmbH throughout the whole transaction process.

Parties

Talk to the deal team

Jan P. Hatje

Managing Partner
Hamburg, Germany
Oaklins Germany

Christian Jellentrup

Director
Hamburg, Germany
Oaklins Germany

Related deals

Lumiforte partners with Kartesia to propel global growth and innovation
Private Equity | Agriculture | Other Industries

Lumiforte partners with Kartesia to propel global growth and innovation

Lumiforte, a global leader in innovative smart coatings for greenhouse horticulture, sports line-marking and other functional coatings for agriculture and industry, is excited to announce an investment from Kartesia, a European specialist in capital solutions for small and medium-sized companies. Horticoop, a longstanding shareholder of Lumiforte and a key player in the horticultural industry through its investment cooperative, continues to remain a shareholder.

Learn more
Yxion has been acquired by Normec
Private Equity | Business Support Services

Yxion has been acquired by Normec

Normec has acquired Dutch consultancy Yxion from Antea. Through this acquisition, Normec continues its acquisition strategy in Europe, while also looking for expansion opportunities in the United States.

Learn more
AMC Media Group has been acquired by Formedics
Healthcare | TMT

AMC Media Group has been acquired by Formedics

AMC Media Group, a healthcare professional (HCP) community platform that enables medical associations and key opinion leaders (KOLs) to drive engagement and monetization through their specialty digital properties, has been acquired by Formedics, an HCP community and engagement platform that is home to Physician’s Weekly and OncWeekly.

Learn more